ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 209,28
-0,12%
Dow Jones
39 431,70
-0,21%
DAX
18 742,22
-0,08%
Brent Oil
83,075
0,84%
Bitcoin
62 701,85
2,04%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Canadá
  5. TSX
  6. Oncolytics Biotech Inc (ONC)

  7. Oncolytics Biotech Inc (ONC) Actualités

ONC

Oncolytics Biotech (ONC)

Oncolytics Biotech Inc
De:
Trier par:
 Showing the most relevant articles for your search:TSX:ONC
DateHeureSourceTitreSymboleSociété
26/09/202314h00PR Newswire (US)THE PANCREATIC CANCER ACTION NETWORK SELECTS ONCOLYTICS BIOTECH® INC. TO RECEIVE $5 MILLION THERAPEUTIC ACCELERATOR AWARD TO DEVELOP LEADING-EDGE TREATMENTSTSX:ONCOncolytics Biotech Inc
01/06/202218h23PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - ONC.WTTSX:ONCOncolytics Biotech Inc
01/06/202218h21PR Newswire (Canada)IIROC Trading Halt - ONC.WTTSX:ONCOncolytics Biotech Inc
10/01/202217h57PR Newswire (US)New Developments in Fight Against Blood Cancers, in Leadup to US$17.1 Billion Market by 2024TSX:ONCOncolytics Biotech Inc
09/04/202117h56PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - ONCTSX:ONCOncolytics Biotech Inc
09/04/202117h56PR Newswire (Canada)IIROC Trade Resumption - ONCTSX:ONCOncolytics Biotech Inc
09/04/202117h53PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - ONCTSX:ONCOncolytics Biotech Inc
09/04/202117h52PR Newswire (Canada)IIROC Trading Halt - ONCTSX:ONCOncolytics Biotech Inc
27/12/201713h00PR Newswire (US)Oncolytics Biotech® Announces Poster Presentation at the 2018 Gastrointestinal Cancers Symposium Sponsored by ASCO in Patien...TSX:ONCOncolytics Biotech Inc
05/12/201713h00PR Newswire (US)Oncolytics Biotech® Receives Favorable Final Advice Letter from the European Medicines Agency for REOLYSIN® in Metastatic B...TSX:ONCOncolytics Biotech Inc
04/12/201713h00PR Newswire (US)Oncolytics Biotech® to Present at the Oncolytic Virotherapy SummitTSX:ONCOncolytics Biotech Inc
30/11/201713h00PR Newswire (US)Oncolytics Biotech® Establishes Scientific Advisory Board Focused on REOLYSIN® Registration Study in Metastatic Breast Canc...TSX:ONCOncolytics Biotech Inc
16/11/201723h00PR Newswire (Canada)Oncolytics Biotech® Inc. and Adlai Nortye Enter into USD $86.6 Million Regional Licensing Agreement for REOLYSIN®TSX:ONCOncolytics Biotech Inc
08/11/201713h00PR Newswire (US)Oncolytics Biotech® Inc. Announces 2017 Third Quarter ResultsTSX:ONCOncolytics Biotech Inc
02/11/201712h00PR Newswire (US)Oncolytics Biotech® Appoints Deborah Brown to Board of DirectorsTSX:ONCOncolytics Biotech Inc
11/10/201713h00PR Newswire (US)Oncolytics Biotech® to Present at the 2017 BIO Investor ForumTSX:ONCOncolytics Biotech Inc
19/09/201713h00PR Newswire (US)Oncolytics Biotech® to Present at the Phacilitate Immuno-Oncology Frontiers ConferenceTSX:ONCOncolytics Biotech Inc
18/09/201713h00PR Newswire (US)Oncolytics Biotech® Announces Successful End-of-Phase 2 Meeting with FDA for REOLYSIN® in Metastatic Breast CancerTSX:ONCOncolytics Biotech Inc
14/09/201713h00PR Newswire (US)Oncolytics Biotech® Announces First Patient Treated in MUK eleven StudyTSX:ONCOncolytics Biotech Inc
11/09/201713h00PR Newswire (US)Oncolytics Biotech® Announces the Presentation of REOLYSIN® Clinical Data at ESMO 2017 CongressTSX:ONCOncolytics Biotech Inc
03/08/201713h00PR Newswire (US)Oncolytics Biotech® Inc. Announces 2017 Second Quarter ResultsTSX:ONCOncolytics Biotech Inc
01/08/201713h00PR Newswire (US)Oncolytics Biotech® Inc. to Present at the Canaccord Genuity 37th Annual Growth ConferenceTSX:ONCOncolytics Biotech Inc
26/07/201713h00PR Newswire (US)Oncolytics Biotech® to Present REOLYSIN® Safety Data in combination with chemotherapy at ESMO 2017 CongressTSX:ONCOncolytics Biotech Inc
29/06/201713h00PR Newswire (Canada)Oncolytics® Biotech Inc. Appoints Andrew de Guttadauro, President of Oncolytics Biotech (U.S.) Inc.TSX:ONCOncolytics Biotech Inc
27/06/201713h00PR Newswire (US)Oncolytics Biotech® Inc. Opens U.S. Based Office in San DiegoTSX:ONCOncolytics Biotech Inc
01/06/201715h44PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - ONC.WTTSX:ONCOncolytics Biotech Inc
01/06/201715h43PR Newswire (Canada)IIROC Trade Resumption - ONC.WTTSX:ONCOncolytics Biotech Inc
01/06/201715h27PR Newswire (US)Oncolytics Biotech® Announces Closing of Public Offering of UnitsTSX:ONCOncolytics Biotech Inc
24/05/201716h39PR Newswire (US)Oncolytics Biotech® Prices Public Offering of UnitsTSX:ONCOncolytics Biotech Inc
24/05/201701h09PR Newswire (US)Oncolytics Biotech® Announces Proposed Public OfferingTSX:ONCOncolytics Biotech Inc
 Showing the most relevant articles for your search:TSX:ONC

Dernières Valeurs Consultées

COIN
BUSDETH
Binance USD
UNSW3
SIEUSDT
Social Intelligent Evolution
NASDAQ
NXPI
NXP Semiconductors NV
XE
MA10
Binect
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés